|
| L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Basic information |
| L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Chemical Properties |
Boiling point | 1059.7±65.0 °C(Predicted) | density | 1.202±0.06 g/cm3(Predicted) | pka | 9.27±0.35(Predicted) |
| L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Usage And Synthesis |
Description | SDZ 283-910 is a statine-derived inhibitor . |
| L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Preparation Products And Raw materials |
|